Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants

Journal of Virology(2023)10.1128/jvi.01070-23Source: DataRank Database

Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants is a research paper published in Journal of Virology (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.67)OA: hybridTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Richard H.C. Huntwork ORCID,Gillian Q. Horn ORCID,Milite Abraha ORCID,Kathryn M. Hastie ORCID,Haoyang Li ORCID

Live enrichment

PubMed:38019013 PMC:PMC10746274 OpenAlex:https://openalex.org/W4389136672

Bill and Melinda Gates Foundation

Grant: INV-008612

Bill and Melinda Gates Foundation

Grant: INV-006133

Bill and Melinda Gates Foundation

Grant: OPP1210938

HHS | National Institutes of Health

Grant: U19 AI142790-03S1

NIAID NIH HHS

Grant: U19 AI142790

National Institutes of Health

Grant: 5U19AI142790-04

Consortium for Immunotherapeutics against Emerging Viral Threats

FWCI

0.67

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/jvi.01070-23

publisherhttps://doi.org/10.1128/jvi.01070-23

publisherhttps://journals.asm.org/doi/pdf/10.1128/jvi.01070-23

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38019013

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10746274

Fields of Study

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchCOVID-19 Clinical Research Studies

MeSH Terms

COVID-19SARS-CoV-2Antibodies, ViralHumansSevere acute respiratory syndrome-related coronavirusAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

BiologyAntibodyNeutralizationEpitopeVirologyBinding siteEpitope mappingVirusGeneticsMonoclonal antibodiesBinding kineticsSurface plasmon resonanceNeutralizing AntibodiesBiolayer InterferometryRbdEpitope BinningCovid-19Sars-cov-2Ace-2 BlockingSevere acute respiratory syndrome-related coronavirusVaccines and Antiviral AgentsSpike Glycoprotein, CoronavirusHumansAntibodies, ViralAntibodies, Neutralizing

Sustainable Development Goals

SDG 0: Good health and well-being

Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants

FAIR Checklist

Authors (19)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)